Back
Protagonist Therapeutics Vs. Summit Midstream Partners LP Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
30.74
Seasonality Move:
16.08%
Buy
66
SMLP
Summit Midstream Partners LP
Last Price:
33.13
Seasonality Move:
3.84%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.74. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Summit Midstream Partners LP (SMLP)
is a Buy
Is Summit Midstream Partners LP a Buy, Sell or Hold?
- The current Summit Midstream Partners LP [SMLP] share price is $33.05. The Score for SMLP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- SMLP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
SMLP Stock Price Chart
What is Summit Midstream Partners LP's stock price today?
-
The Summit Midstream Partners LP share price today is $33.05
The current trend is moderately bullish and SMLP is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 65.8 | Buy |
| Chaikin Money Flow: | -378836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.92 - 29.04) | Buy |
| Bollinger Bands (100): | (24.71 - 29.41) | Buy |
SMLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 61.7 | Buy |
| Chaikin Money Flow: | -16684 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.76 - 33.68) | Buy |
| Bollinger Bands (100): | (16.47 - 28.79) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.59 | Buy |
| 20-day SMA: | 27.27 | Buy |
| 50-day SMA: | 27.76 | Buy |
| 200-day SMA: | 22.41 | Buy |
| 8-day EMA: | 29.73 | Buy |
| 20-day EMA: | 28.24 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 24.11 | Buy |
SMLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.72 | Sell |
| 20-day SMA: | 31.39 | Buy |
| 50-day SMA: | 27.73 | Buy |
| 200-day SMA: | 19.68 | Buy |
| 8-day EMA: | 33.35 | Sell |
| 20-day EMA: | 31.81 | Buy |
| 50-day EMA: | 28.27 | Buy |
| 200-day EMA: | 21.6 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Summit Midstream Partners LP Earnings Growth & SMLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Midstream Partners LP Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||